Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02867163 · ClinicalTrials.gov registry record
Tranexamic Acid and Blood Clots in Knee Surgery
A clinical trial of Venous Thrombosis, sponsored by University of New Mexi.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT02867163: Completed study of Venous Thrombosis, sponsored by University of New Mexi.
NCT02867163 is a study of Venous Thrombosis that has completed, run by University of New Mexi. The registered enrollment target is 25 participants, below the 1,122-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02867163, a study of Venous Thrombosis, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational trial to estimate the incidence of deep vein thrombosis (DVT) in total knee replacement patients who received an intraoperative dose of tranexamic acid.
Primary Outcome
Incidence of deep vein thrombosis diagnosed by ultrasound scan on postoperative day 1
Conditions Studied
Interventions
- DRUG Tranexamic Acid
Study Locations (1)
New Mexico
- Sandoval Regional Medical Center - Rio Rancho
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-05-16 |
| Est. Completion | 2017-11-08 |
What the finished NCT02867163 record still lists
NCT02867163 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,122-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Venous Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Tranexamic Acid is the first listed.
NCT02867163 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT02867163 about?
NCT02867163 is a clinical study titled "Tranexamic Acid and Blood Clots in Knee Surgery". This is an observational trial to estimate the incidence of deep vein thrombosis (DVT) in total knee replacement patients who received an intraoperative dose of tranexamic acid.
What is the current status of trial NCT02867163?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2017-05-16. Estimated completion is 2017-11-08.
What conditions does trial NCT02867163 study?
This clinical trial studies the following conditions: Venous Thrombosis.
What interventions are being tested in trial NCT02867163?
The interventions under investigation include: Tranexamic Acid (DRUG).
Who is sponsoring clinical trial NCT02867163?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02867163 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02867163's enrollment target sits among peer trials
25 9th of 9 higher than 1 of 9 other Venous Thrombosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Thrombosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
JETi Lower Extremity Venous Thrombosis
ACTIVE NOT RECRUITING
-
Registry of AngioJet Use in the Peripheral Vascular System
COMPLETED
-
Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters
COMPLETED · NA
-
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
-
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
COMPLETED · NA
-
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI